← Therapeutics
Details checkedClinical trial listing onlyHistorical/discontinuedCheckedregistry
Nitrous oxide tinnitus crossover trial
Also known as: Nitrous Oxide Gas For Inhalation, Nitrous oxide treatment for tinnitus
Institution-led study
Sponsor / Institution
Institution-led study
Program Type
Therapeutic
Modality
Small Molecule/Inhaled Gas
Stage
Phase 4
Status
Completed
Target Gene
—
Route / Mode
Inhaled gas
Confidence
87%
Status Confidence
Status needs checking
Evidence Strength
Needs more support
Last Reviewed
2026-06-10
Geography
United States
Population
adult, tinnitus
Trial IDs
1
Mechanism
Randomized double-blind crossover trial of 50% nitrous oxide/50% oxygen versus placebo gas for tinnitus.
Indications
Notes
Registry-verified academic tinnitus trial. This is a historical study of a generic anesthetic gas, not a current company-sponsored hearing therapeutic program.
Evidence & Sources
1 structured sourcesclinicaltrials
Supports: canonicalName, company, allCompanies, isIndustrySponsored, programType, modality, mechanism, indications...
IDs: NCT03365011
Key Events
Clinical Trials (1)
Data Checks
institution-led-studyregistry-only-evidencehistorical-studynot-confirmed-current-product
Related Programs
AC102 by AudioCure Pharma
Company: AudioCure Pharma · Small Molecule · Phase 2
SPI-1005 by Sound Pharmaceuticals
Company: Sound Pharmaceuticals · Small Molecule · Phase 3
OTO-313 by Otonomy
Company: Otonomy · Small Molecule · Phase 2
AM-101 by Auris Medical and Altamira
Company: Altamira Therapeutics · Small Molecule · Phase 3
NHPN-1010
Company: Otologic Pharmaceutics · Small Molecule · Phase 1
OTO-104 (dexamethasone) by Otonomy
Company: Otonomy · Steroid/Anti-inflammatory · Phase 3